Loading grant details…
Active
RESEARCH CENTERS
NIH (US)
Project 4: Neoadjuvant Clinical Trial with Pembrolizumab for Locally Advanaced Squamous Cell Carcinoma (SCC)
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of Pittsburgh At Pittsburgh |
| Country | United States |
| Start Date | Jul 01, 2024 |
| End Date | Jun 30, 2026 |
| Duration | 729 days |
| Number of Grantees | 2 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 11175542 |
Grant Description
This is a phase II single-arm neoadjuvant pembrolizumab trial in patients with PD-1 naïve resectable locally advanced SCC.
All Grantees
University of Pittsburgh At Pittsburgh
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2024
End Year
2026
Grantees
2
Related Grants
Advertisement
